Dr. Daniel Ahoubim, M.D.
Neurology (Neurology Physician)
18370 Burbank Blvd Ste 414
Tarzana, CA 91356
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 19
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 313
Licensed in California since 2016, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CA license A144380 (first issued 2016; current) · FL license ME113707 · NY license 250505 -
Sleep Medicine (Psychiatry & Neurology) Physician
FL license ME113707
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Good Samaritan Hospital Medical Center West Islip, NY
- Peconic Bay Medical Center Riverhead, NY
- Chsli St Joseph Hospital Bethpage, NY
- Valley Presbyterian Hospital Van Nuys, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 313
- Services billed
- 1,071
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 226 | 102 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 133 | 123 |
| Critical care, first 30-74 minutes | 87 | 30 |
| Established patient office or other outpatient visit, 30-39 minutes | 64 | 40 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 54 | 47 |
| New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Memantine Hcl Other prescribers in Tarzana, CA | 93 |
| Trazodone Hcl Other prescribers in Tarzana, CA | 40 |
| Nortriptyline Hcl Other prescribers in Tarzana, CA | 29 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Tarzana, CA | 22 |
| Propranolol Hcl Er (propranolol hcl) Other prescribers in Tarzana, CA | 19 |
| Escitalopram Oxalate Other prescribers in Tarzana, CA | 17 |
| Gabapentin Other prescribers in Tarzana, CA | 16 |
| Quetiapine Fumarate Er (quetiapine fumarate) Other prescribers in Tarzana, CA | 15 |
| Nourianz (istradefylline) | 14 |
| Pregabalin Other prescribers in Tarzana, CA | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 54 payments worth $1,304 in total to this clinician.
| AbbVie Inc. | $163 |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $126 |
| Novartis Pharmaceuticals Corporation | $102 |
| Lundbeck LLC | $83.09 |
| Otsuka America Pharmaceutical, Inc. | $78.81 |
| Harmony Biosciences LLC | $71.18 |
| Lilly USA, LLC | $64.97 |
| Eisai Inc. | $64.79 |
| Food and Beverage | $1,276 |
|---|---|
| Education | $28.63 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Jul 10, 2025 | Education UPLIZNA · Inflammation/Rare Disease · in-kind | $28.63 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.